Previously not recognized deletion in presenilin-1 (p.Leu174del.) in a patient with early-onset familial Alzheimer's disease

Neuroscience Letters

Volumn 544, Issue , 2013, Pages 115-118

  Tiedt, H O ^a   Lueschow, A ^a   Winter, P ^b   Muller U ^b  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b JUSTUS LIEBIG UNIVERSITY   (Germany)

Author keywords

Early onset Alzheimer's disease; Familial Alzheimer's disease; Frontotemporal dementia; Presenilin; PSEN1 mutation

Indexed keywords

AMYLOID BETA PROTEIN[1-40]; AMYLOID BETA PROTEIN[1-42]; CITALOPRAM; DONEPEZIL; LEUCINE; PRESENILIN 1; TAU PROTEIN;

ADULT; ALZHEIMER DISEASE; AMNESIA; ARTICLE; BRAIN ATROPHY; CASE REPORT; CEREBROSPINAL FLUID EXAMINATION; CODON; COGNITIVE DEFECT; DEPRESSION; DNA SEQUENCE; EARLY ONSET ALZHEIMER DISEASE; EXON; GENE DELETION; GENETIC SCREENING; HUMAN; MALE; MILD COGNITIVE IMPAIRMENT; MINI MENTAL STATE EXAMINATION; MISSENSE MUTATION; NEUROIMAGING; NEUROPSYCHOLOGICAL TEST; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PSYCHOMETRY; VERBAL MEMORY; WORD LIST RECALL; WORD RECOGNITION;

ALZHEIMER DISEASE; GENE DELETION; GENETIC MARKERS; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; POLYMORPHISM, SINGLE NUCLEOTIDE; PRESENILIN-1;

EID: 84878379947     PISSN: 03043940     EISSN: 18727972     Source Type: Journal    
DOI: 10.1016/j.neulet.2013.03.056     Document Type: Article

References (33)

1. Bertoli Avella A.M., Marcheco Teruel B., Llibre Rodriguez J.J., Gomez Viera N., Borrajero Martinez I., Severijnen E.A., Joosse M., van Duijn C.M., Heredero Baute L., Heutink P. A novel presenilin 1 mutation (L174 M) in a large Cuban family with early onset Alzheimer disease. Neurogenetics 2002, 4:97-104.
2. Blennow K., Hampel H., Weiner M., Zetterberg H. Cerebrospinal fluid and plasma biomarkers in Alzheimer disease. Nature Rev. Neurol. 2010, 6:131-144.
3. Boyle J.P., Hettiarachchi N.T., Wilkinson J.A., Pearson H.A., Scragg J.L., Lendon C., Al-Owais M.M., Kim C.B., Myers D.M., Warburton P., Peers C. Cellular consequences of the expression of Alzheimer's disease-causing presenilin 1 mutations in human neuroblastoma (SH-SY5Y) cells. Brain Res. 2012, 1443:75-88.
4. Chavez-Gutierrez L., Bammens L., Benilova I., Vandersteen A., Benurwar M., Borgers M., Lismont S., Zhou L., Van Cleynenbreugel S., Esselmann H., Wiltfang J., Serneels L., Karran E., Gijsen H., Schymkowitz J., Rousseau F., Broersen K., De Strooper B. The mechanism of gamma-secretase dysfunction in familial Alzheimer disease. EMBO J. 2012, 31:2261-2274.
5. De Strooper B. Aph-1, Pen-2, and nicastrin with presenilin generate an active gamma-Secretase complex. Neuron 2003, 38:9-12.
6. Dubois B., Feldman H.H., Jacova C., Dekosky S.T., Barberger-Gateau P., Cummings J., Delacourte A., Galasko D., Gauthier S., Jicha G., Meguro K., O'Brien J., Pasquier F., Robert P., Rossor M., Salloway S., Stern Y., Visser P.J., Scheltens P. Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS-ADRDA criteria. Lancet Neurol. 2007, 6:734-746.
7. Ehrensperger M.M., Berres M., Taylor K.I., Monsch A.U. Early detection of Alzheimer's disease with a total score of the German CERAD. J. Int. Neuropsychol. Soc. 2010, 16:910-920.
8. Ezquerra M., Carnero C., Blesa R., Gelpi J.L., Ballesta F., Oliva R. A presenilin 1 mutation (Ser169Pro) associated with early-onset AD and myoclonic seizures. Neurology 1999, 52:566-570.
9. Ezquerra M., Carnero C., Blesa R., Oliva R. A novel presenilin 1 mutation (Leu166Arg) associated with early-onset Alzheimer disease. Arch. Neurol. 2000, 57:485-488.
10. Golan M.P., Styczynska M., Jozwiak K., Walecki J., Maruszak A., Pniewski J., Lugiewicz R., Filipek S., Zekanowski C., Barcikowska M. Early-onset Alzheimer's disease with a de novo mutation in the presenilin 1 gene. Exp. Neurol. 2007, 208:264-268.
11. Guo J., Wei J., Liao S., Wang L., Jiang H., Tang B. A novel presenilin 1 mutation (Ser169del) in a Chinese family with early-onset Alzheimer's disease. Neurosci. Lett. 2010, 468:34-37.
12. Janssen J.C., Beck J.A., Campbell T.A., Dickinson A., Fox N.C., Harvey R.J., Houlden H., Rossor M.N., Collinge J. Early onset familial Alzheimer's disease: mutation frequency in 31 families. Neurology 2003, 60:235-239.
13. Kalbe E., Kessler J., Calabrese P., Smith R., Passmore A.P., Brand M., Bullock R. DemTect: a new, sensitive cognitive screening test to support the diagnosis of mild cognitive impairment and early dementia. Int. J. Geriatr. Psychiatry 2004, 19:136-143.
14. Klunemann H.H., Rogaeva E., Neumann M., Kretzschmar H.A., Kandel M., Toulina A., Sato C., Salehi-Rad S., Pfister K., Klein H.E., St George-Hyslop P.H. Novel PS1 mutation in a Bavarian kindred with familial Alzheimer disease. Alzheimer Dis. Assoc. Disord. 2004, 18:256-258.
15. Knight W.D., Kennedy J., Mead S., Rossor M.N., Beck J., Collinge J., Mummery C. A novel presenilin 1 deletion (p.L166del) associated with early onset familial Alzheimer's disease. Eur. J. Neurol. 2007, 14:829-831.
16. Langheinrich T.C., Romanowski C.A., Wharton S., Hadjivassiliou M. Presenilin-1 mutation associated with amnesia, ataxia, and medial temporal lobe T2 signal changes. Neurology 2011, 76:1435-1436.
17. Larner A.J., Doran M. Clinical phenotypic heterogeneity of Alzheimer's disease associated with mutations of the presenilin-1 gene. J. Neurol. 2006, 253:139-158.
18. Larner A.J., Doran M. Genotype-phenotype relationships of presenilin-1 mutations in Alzheimer's disease: an update. J. Alzheimers Dis. 2009, 17:259-265.
19. Larner A.J., du Plessis D.G. Early-onset Alzheimer's disease with presenilin-1 M139 V mutation: clinical, neuropsychological and neuropathological study. Eur. J. Neurol. 2003, 10:319-323.
20. Lyketsos C.G., Carrillo M.C., Ryan J.M., Khachaturian A.S., Trzepacz P., Amatniek J., Cedarbaum J., Brashear R., Miller D.S. Neuropsychiatric symptoms in Alzheimer's disease. Alzheimer's Dement. 2011, 7:532-539.
21. Mendez M.F., McMurtray A. Frontotemporal dementia-like phenotypes associated with presenilin-1 mutations. Am. J. Alzheimers Dis. Other Demen. 2006, 21:281-286.
22. Ott A., Breteler M.M., van Harskamp F., Stijnen T., Hofman A. Incidence and risk of dementia. The Rotterdam study. Am. J. Epidemiol. 1998, 147:574-580.
23. Piccini A., Zanusso G., Borghi R., Noviello C., Monaco S., Russo R., Damonte G., Armirotti A., Gelati M., Giordano R., Zambenedetti P., Russo C., Ghetti B., Tabaton M. Association of a presenilin 1 S170F mutation with a novel Alzheimer disease molecular phenotype. Arch. Neurol. 2007, 64:738-745.
24. Raux G., Guyant-Marechal L., Martin C., Bou J., Penet C., Brice A., Hannequin D., Frebourg T., Campion D. Molecular diagnosis of autosomal dominant early onset Alzheimer's disease: an update. J. Med. Genet. 2005, 42:793-795.
25. Rotzoll M., Fuchs P., Richter P., Hohendorf G. Nazi action T4 euthanasia programme: historical research, individual life stories and the culture of remembrance. Nervenarzt 2010, 81:1326-1332.
26. Sepulveda-Falla D., Glatzel M., Lopera F. Phenotypic profile of early-onset familial Alzheimer's disease caused by presenilin-1 E280A mutation. J. Alzheimers Dis. 2012, 32:1-12.
27. Snider B.J., Norton J., Coats M.A., Chakraverty S., Hou C.E., Jervis R., Lendon C.L., Goate A.M., McKeel D.W., Morris J.C. Novel presenilin 1 mutation (S170F) causing Alzheimer disease with Lewy bodies in the third decade of life. Arch. Neurol. 2005, 62:1821-1830.
28. Spalletta G., Musicco M., Padovani A., Rozzini L., Perri R., Fadda L., Canonico V., Trequattrini A., Pettenati C., Caltagirone C., Palmer K. Neuropsychiatric symptoms and syndromes in a large cohort of newly diagnosed, untreated patients with Alzheimer disease. Am. J. Geriatr. Psychiatry 2010, 18:1026-1035.
29. Spasic D., Tolia A., Dillen K., Baert V., De Strooper B., Vrijens S., Annaert W. Presenilin-1 maintains a nine-transmembrane topology throughout the secretory pathway. J. Biol. Chem. 2006, 281:26569-26577.
30. Taddei K., Kwok J.B., Kril J.J., Halliday G.M., Creasey H., Hallupp M., Fisher C., Brooks W.S., Chung C., Andrews C., Masters C.L., Schofield P.R., Martins R.N. Two novel presenilin-1 mutations (Ser169Leu and Pro436Gln) associated with very early onset Alzheimer's disease. Neuroreport 1998, 9:3335-3339.
31. Tedde A., Nacmias B., Ciantelli M., Forleo P., Cellini E., Bagnoli S., Piccini C., Caffarra P., Ghidoni E., Paganini M., Bracco L., Sorbi S. Identification of new presenilin gene mutations in early-onset familial Alzheimer disease. Arch. Neurol. 2003, 60:1541-1544.
32. Tierney M.C., Fisher R.H., Lewis A.J., Zorzitto M.L., Snow W.G., Reid D.W., Nieuwstraten P. The NINCDS-ADRDA Work Group criteria for the clinical diagnosis of probable Alzheimer's disease: a clinicopathologic study of 57 cases. Neurology 1988, 38:359-364.
33. Tolia A., De Strooper B. Structure and function of gamma-secretase. Semin. Cell Dev. Biol. 2009, 20:211-218.